Meazza et al. noted that the upregulation of HLA-DR after introduction of exogenous CIITA led to T cell activation and tumor rejection, suggesting that CIITA could be a valuable target for future therapeutics [60]. The gene discussed is CIITA; the disease is neoplasm.